- Home
- BNR vs CLIR Comparison
BNR vs CLIR Comparison
Compare BNR & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- CLIR
- Stock Information
- Founded
- BNR 2014
- CLIR 2008
- Country
- BNR China
- CLIR United States
- Employees
- BNR N/A
- CLIR N/A
- Industry
- BNR Medical Specialities
- CLIR Industrial Machinery/Components
- Sector
- BNR Health Care
- CLIR Industrials
- Exchange
- BNR Nasdaq
- CLIR Nasdaq
- Market Cap
- BNR 29.1M
- CLIR 32.5M
- IPO Year
- BNR 2020
- CLIR 2012
- Fundamental
- Price
- BNR $3.86
- CLIR $0.55
- Analyst Decision
- BNR
- CLIR Strong Buy
- Analyst Count
- BNR 0
- CLIR 1
- Target Price
- BNR N/A
- CLIR $2.00
- AVG Volume (30 Days)
- BNR 35.7K
- CLIR 49.8K
- Earning Date
- BNR 08-21-2025
- CLIR 08-13-2025
- Dividend Yield
- BNR N/A
- CLIR N/A
- EPS Growth
- BNR N/A
- CLIR N/A
- EPS
- BNR N/A
- CLIR N/A
- Revenue
- BNR $72,112,038.00
- CLIR $2,895,000.00
- Revenue This Year
- BNR $136.32
- CLIR $27.61
- Revenue Next Year
- BNR N/A
- CLIR $116.19
- P/E Ratio
- BNR N/A
- CLIR N/A
- Revenue Growth
- BNR 0.53
- CLIR 10.88
- 52 Week Low
- BNR $2.18
- CLIR $0.46
- 52 Week High
- BNR $7.90
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- BNR 62.38
- CLIR 43.26
- Support Level
- BNR $3.06
- CLIR $0.50
- Resistance Level
- BNR $3.50
- CLIR $0.60
- Average True Range (ATR)
- BNR 0.23
- CLIR 0.06
- MACD
- BNR 0.03
- CLIR -0.00
- Stochastic Oscillator
- BNR 87.26
- CLIR 39.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.